Business Context and Reporting Period
This Form 8-K is a current report filed by AIT Therapeutics, Inc. (not Beyond Air, Inc.) on May 3, 2019. The registrant is an emerging growth company incorporated in Delaware. The report addresses a specific corporate event occurring on the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a listing approval and does not contain financial statements or performance metrics.
Material Changes
- Nasdaq Listing Approval: On May 3, 2019, the company announced the approval of its application to list its common stock on The Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies beyond the announcement of the listing approval. No unusual items were reported in this specific document.
Investor Verification Checklist
- Verify the ticker symbol and trading status on The Nasdaq Capital Market following the May 3, 2019 approval.
- Confirm the company name is AIT Therapeutics, Inc., as the input metadata referenced "Beyond Air, Inc."
- Review the full text of the press release (Exhibit 99.1) for details on the listing process.
- Check subsequent filings (10-K or 10-Q) for financial data, as this 8-K contains none.